111 Capital Invests $413,000 in Privia Health Group, Inc. $PRVA

Key Points

• 111 Capital has invested approximately $413,000 in Privia Health Group by acquiring 17,954 shares in the second quarter, according to a Form 13F filing.
• Multiple institutional investors have significantly increased their holdings in Privia Health Group, with CWM LLC and Bessemer Group Inc. upping their positions by over 50% and 2,393% respectively.
• Privia Health Group reported $521.15 million in revenue for the last quarter, exceeding analyst expectations, but missed EPS estimates with a reported $0.02 EPS.

111 Capital bought a new position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 17,954 shares of the company's stock, valued at approximately $413,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. CWM LLC increased its position in shares of Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company's stock worth $40,000 after purchasing an additional 604 shares during the last quarter. Bessemer Group Inc. increased its position in shares of Privia Health Group by 2,393.4% in the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock worth $51,000 after purchasing an additional 2,178 shares during the last quarter. Russell Investments Group Ltd. increased its position in shares of Privia Health Group by 2,852.2% in the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company's stock worth $60,000 after purchasing an additional 2,567 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Privia Health Group by 113.1% in the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock worth $64,000 after purchasing an additional 1,521 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its position in shares of Privia Health Group by 2,115.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company's stock worth $75,000 after purchasing an additional 3,173 shares during the last quarter. Institutional investors own 94.48% of the company's stock.

Privia Health Group Price Performance

NASDAQ PRVA opened at $24.09 on Monday. The company's 50 day simple moving average is $21.99 and its 200 day simple moving average is $22.42. Privia Health Group, Inc. has a 12 month low of $16.47 and a 12 month high of $26.09. The company has a market capitalization of $2.96 billion, a P/E ratio of 219.02, a PEG ratio of 3.29 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The business had revenue of $521.15 million during the quarter, compared to the consensus estimate of $466.97 million. During the same quarter in the previous year, the firm earned $0.19 earnings per share. The firm's revenue for the quarter was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS. On average, analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on PRVA shares. Zacks Research raised shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a research report on Tuesday, August 19th. Stephens reaffirmed an "overweight" rating and set a $32.00 price objective on shares of Privia Health Group in a research report on Wednesday, September 24th. Piper Sandler lowered their price objective on shares of Privia Health Group from $36.00 to $35.00 and set an "overweight" rating for the company in a research report on Monday, August 11th. JMP Securities boosted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "market outperform" rating in a research report on Friday, August 29th. Finally, Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Privia Health Group in a research report on Saturday, September 27th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $28.58.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.